Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q1 earnings results on Thursday, May 4, 2023 at 06:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Aurinia Pharmaceuticals beat estimated earnings by 18.18%, reporting an EPS of $-0.18 versus an estimate of $-0.22.
Revenue was up $12.78 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 1.1% drop in the share price the next day.
Here’s a look at Aurinia Pharmaceuticals’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.27 | -0.17 | -0.22 | -0.27 |
| EPS Actual | -0.18 | -0.06 | -0.25 | -0.27 |
| Revenue Estimate | 27.78M | 36.18M | 27.14M | 19.76M |
| Revenue Actual | 28.43M | 55.78M | 28.19M | 21.62M |
To track all earnings releases for Aurinia Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
